Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity

  • Thomas A. Wadden
    Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia
  • Timothy S. Bailey
    AMCR Institute, Escondido, California
  • Liana K. Billings
    Department of Medicine, NorthShore University HealthSystem/University of Chicago Pritzker School of Medicine, Skokie, Illinois
  • Melanie Davies
    Diabetes Research Centre, University of Leicester, Leicester, United Kingdom
  • Juan P. Frias
    National Research Institute, Los Angeles, California
  • Anna Koroleva
    Novo Nordisk A/S, Søborg, Denmark
  • Ildiko Lingvay
    Departments of Internal Medicine/Endocrinology and Population and Data Sciences, University of Texas Southwestern Medical Center, Dallas
  • Patrick M. O’Neil
    Weight Management Center, Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston
  • Domenica M. Rubino
    Washington Center for Weight Management and Research, Arlington, Virginia
  • Dorthe Skovgaard
    Novo Nordisk A/S, Søborg, Denmark
  • Signe O. R. Wallenstein
    Novo Nordisk A/S, Søborg, Denmark
  • W. Timothy Garvey
    Department of Nutrition Sciences, University of Alabama at Birmingham

Bibliographic Information

Other Title
  • The STEP 3 Randomized Clinical Trial

Journal

  • JAMA

    JAMA 325 (14), 1403-, 2021-04-13

    American Medical Association (AMA)

Citations (2)*help

See more

Report a problem

Back to top